Targeting Gleevec resistance in CML patients: Tumor suppressor p53 suppressed miR-144/451 contributes to the gleevec sensitivity in CML, 7/November/2013, 7.03 am

Lin-28 increases the oncomiR miR-92 expression via down regulation of its target gene, 7/November/2013, 6.46 am
November 7, 2013
Targeting cancer metastasis and invasion: Metformin induces the metastasis suppressor E-Cadherin expression, 7/November/2013, 7.34 am
November 7, 2013
Show all

Idea Proposed byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, Targeting Gleevec resistance in CML patients: Tumor suppressor p53 suppressed miR-144/451 contributes to the gleevec sensitivity in CML, 7/November/2013, 7.03 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Comments are closed.